Upacicalcet for hyperparathyroidism, secondary

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 22 Oct 2026: Trial registered, NCT07890584

The trials

NCT07890584: A Study of PLS240 in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

State
Not started
Phase
Phase 3
People
56 planned
Started
30 Oct 2026
Primary completion
22 Feb 2032
Arms
Cohort 1, Cohort 2
Results
None posted
  1. 22 Oct 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.